Current Situation and Analysis of ICU Management for Severe Trauma Patients in China (NJJLISTP)

June 26, 2021 updated by: Lulu Gu

Current Situation and Analysis of ICU Management in Severe Trauma Patients: A Survey From 12 Provinces in China

Over the past 10 years, there has not been a consensus on ICU nursing management based on the concept of injury control. Case management for patients with serious trauma continues to be initiated in general services and after discharge.There is no critical care unit case management strategy for the high-risk population following acute intake. Consequently, there is an urgent need to develop and enhance ICU nursing best practice after injury control.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Jiangsu
      • Nanjing, Jiangsu, China, 210000
        • Jinling Hosp Res Inst of general surgery,Nanjing Univ Sch Med

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Formally hired, and working in ICU for more than 6 months, with ICU trauma patient management experience

Description

Inclusion Criteria:

  • Registered nurses, doctors, and rehabilitation technicians on the job;
  • Formally hired, and working in ICU for more than 6 months, with ICU patient management experience;
  • Voluntary participation in this survey.

Exclusion Criteria:

  • retirees, interns/nurses/rehabilitation technicians, staff on leave, regular training doctors, and departmental nurses;
  • those who are unwilling to participate in this survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ICU management for patients with severe trauma
Group to investigate the current status of ICU management for patients with severe trauma
Other: No Intervention
No Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognition of ICU severe trauma patient
Time Frame: 20 days
The management status of severe trauma patients: including 5 dimensions of risk factor management, related complications management, ICU transition ward preparation plan, discharge preparation plan, and doctor-patient communication
20 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lulu Gu

Investigators

  • Principal Investigator: Xianghong Ye, Jinling Hosp Res Inst of general surgery,Nanjing Univ,Sch Med

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 27, 2021

Primary Completion (Anticipated)

June 27, 2021

Study Completion (Anticipated)

December 27, 2021

Study Registration Dates

First Submitted

June 15, 2021

First Submitted That Met QC Criteria

June 26, 2021

First Posted (Actual)

June 29, 2021

Study Record Updates

Last Update Posted (Actual)

June 29, 2021

Last Update Submitted That Met QC Criteria

June 26, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20210615
  • 18CXZ040 (Other Grant/Funding Number: Xianghong Ye)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma Injury

Clinical Trials on No Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe